This inventor holds 4 USPTO granted patents. Top assignees: Shionogi Company Limited, Shionogi Seiyaku Kabushiki Kaisha. Active years: 1992-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hyogo, JP (1992)
- Amagasaki, JP (1994)
- Higashiosaka, JP (1995 - 1996)
Company Filing History:

Years Active: 1992-1996
Title: The Innovative Contributions of Yoshitaka Araki
Introduction
Yoshitaka Araki is a notable inventor based in Higashiosaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of triterpene derivatives and endothelin-receptor antagonists. With a total of 4 patents to his name, Araki's work has implications for the treatment of diseases associated with excessive secretion of endothelin.
Latest Patents
Araki's latest patents focus on triterpene derivatives and endothelin-receptor antagonists. These compounds are characterized by specific formulas that include metabolic ester residues and various functional groups. The innovative nature of these compounds lies in their anti-endothelin activities, which are crucial for the prophylaxis and treatment of related diseases.
Career Highlights
Throughout his career, Yoshitaka Araki has worked with prominent companies in the pharmaceutical industry, including Shionogi Company Limited and Shionogi Seiyaku Kabushiki Kaisha. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical science.
Collaborations
Araki has collaborated with esteemed colleagues such as Toshiro Konoike and Tetsuyoshi Hayashi. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Yoshitaka Araki's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of treatments for diseases related to endothelin secretion.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile